These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 996301)

  • 1. Somatomedin in chronic liver disease.
    Marek J; Schüllerová M; Schreiberová O
    Rev Czech Med; 1976; 22(4):194-200. PubMed ID: 996301
    [No Abstract]   [Full Text] [Related]  

  • 2. [Somatomedin in chronic liver diseases].
    Marek J; Schüllerová M; Schreiberová O
    Cas Lek Cesk; 1976 Feb; 115(7):209-12. PubMed ID: 1260823
    [No Abstract]   [Full Text] [Related]  

  • 3. [Somatomedins--a review. 2. Age and nutrition dependence, somatomedin concentration in endocrine and non-endocrine diseases].
    Jahreis G; Hesse V
    Kinderarztl Prax; 1983 Sep; 51(9):403-12. PubMed ID: 6656098
    [No Abstract]   [Full Text] [Related]  

  • 4. Radioimmunoassay of serum IGF-I and IGF-II in patients with chronic liver diseases and hepatocellular carcinoma with or without hypoglycemia.
    Wu JC; Daughaday WH; Lee SD; Hsiao TS; Chou CK; Lin HD; Tsai YT; Chiang BN
    J Lab Clin Med; 1988 Nov; 112(5):589-94. PubMed ID: 2460570
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Plasma somatomedin C/insulin-like growth factor I in liver diseases].
    Yoshitsugu M; Sekiya Y; Ihori M
    Nihon Shokakibyo Gakkai Zasshi; 1986 Jul; 83(7):1350-4. PubMed ID: 3784066
    [No Abstract]   [Full Text] [Related]  

  • 6. Insulin-like growth factors (IGF) in liver disease: differential changes of IGF-I and IGF-II.
    Sheppard MS; Minuk GY; Bhaumick B; Bala RM
    Clin Invest Med; 1987 Mar; 10(2):49-53. PubMed ID: 3581545
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Serum alpha-1 fetoprotein in chronic liver diseases].
    Weisz G; Udvardy M; Dalmi L; Kulcsár A
    Orv Hetil; 1982 Aug; 123(34):2091-7. PubMed ID: 6182517
    [No Abstract]   [Full Text] [Related]  

  • 8. [Determination of zinc in chronic liver diseases].
    Weber P; Martínek K; Novotná H; Dastych M
    Cas Lek Cesk; 1987 Nov; 126(45):1402-5. PubMed ID: 3427592
    [No Abstract]   [Full Text] [Related]  

  • 9. Circulating thyroxine in chronic active liver disease.
    Barzilai DC; Soloway RD; Summerskill WH; Schoenfield LJ
    Isr J Med Sci; 1974 Nov; 10(11):1405-14. PubMed ID: 4443216
    [No Abstract]   [Full Text] [Related]  

  • 10. Abnormalities of serum monoamine oxidase in chronic liver disease.
    McEwen CM; Castell DO
    J Lab Clin Med; 1967 Jul; 70(1):36-47. PubMed ID: 6027096
    [No Abstract]   [Full Text] [Related]  

  • 11. [Study of total insulin activity and the content of free insulin in the blood in chronic diffuse liver diseases].
    Rostomova LT; Kurashvili RB
    Ter Arkh; 1974; 46(12):87-90. PubMed ID: 4454029
    [No Abstract]   [Full Text] [Related]  

  • 12. [Coagulative and fibrinolytic blood activity in chronic liver diseases].
    Kaniak J; Kotschy M; Kowal-Gierczak B; Plamieniak L
    Pol Tyg Lek; 1974 Sep; 29(38):1621-4. PubMed ID: 4408958
    [No Abstract]   [Full Text] [Related]  

  • 13. M-components in patients with chronic liver disease.
    Ellman LL; Pachas WN; Pinals RS; Bloch KJ
    Gastroenterology; 1969 Aug; 57(2):138-42. PubMed ID: 5799671
    [No Abstract]   [Full Text] [Related]  

  • 14. [Conjugated serum bile acids in chronic liver diseases and cholestasis].
    Frosch B; Wagener H
    Acta Hepatosplenol; 1971; 18(4):273-86. PubMed ID: 5110093
    [No Abstract]   [Full Text] [Related]  

  • 15. [Metabolic markers of chronic liver disease].
    de Marquez ML; Tombazzi C; Camacho G; Mata M; Carvajal R; Lecuna V
    G E N; 1995; 49(1):1-6. PubMed ID: 8566666
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Eicosanoids in chronic liver diseases].
    Malaia LT; Grishina EI; Babak OIa; Iabluchanskií NI
    Klin Med (Mosk); 1991 Mar; 69(3):48-51. PubMed ID: 2067335
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Monitoring glucose tolerance and blood insulin in patients with chronic liver disease with a 5 year clinical history].
    Oehler G; Bleyl H; Matthes K
    Med Welt; 1983 Sep; 34(37):995-7. PubMed ID: 6355750
    [No Abstract]   [Full Text] [Related]  

  • 18. [Assessment of the gluconeogenetic function of the liver on the basis of blood lactate elimination in patients with acute and chronic liver damage (author's transl)].
    Pryzjemski J; Wlasiuk M; Chrostowska H
    Przegl Lek; 1976; 33(12):979-83. PubMed ID: 1013383
    [No Abstract]   [Full Text] [Related]  

  • 19. [Content of glycoproteids in the blood serum of the patients with chronic inflammatory diseases of the biliary tract and liver].
    Borevskaia BD; Gubergrits EA
    Vrach Delo; 1967 Feb; 2():14-6. PubMed ID: 5617012
    [No Abstract]   [Full Text] [Related]  

  • 20. [Fasting and postprandial serum bile acids in chronic liver diseases].
    Testa R; Dellepiane F; Rovida S; Lapertosa G; Domina AR; Virdis MG; Risso D; Mansi C; Picciotto A; Savarino V; Celle G
    Minerva Dietol Gastroenterol; 1982; 28(3):195-200. PubMed ID: 7145170
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.